Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07172074 · ClinicalTrials.gov registry record · NA
Comparing Relative Strengths of Statistical Associations Between Psychological Traits and Vaccination-Related Outcomes I
A NA study, sponsored by University of Iowa.
- Completed
- Registry status
- NA
- Development phase
- 1,786
- Enrollment target
NCT07172074: Completed NA study, sponsored by University of Iowa.
NCT07172074 is a NA study that has completed, run by University of Iowa. The registered enrollment target is 1,786 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (27% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07172074, a NA study, has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,786 participants
- Enrollment target
Study Summary
The goal of this study was to identify psychological motives that had the strongest statistical associations with vaccine outcomes in order to identify novel intervention targets to be used in vaccine promotion efforts. A national sample of US adults completed an online survey containing a variety of vaccine-related measures and psychological trait measures.
Primary Outcome
Feelings towards vaccines on a 7-point scale, with Very negative (1) and Very positive (7) as the scale anchors
Interventions
- DIAGNOSTIC_TEST General Psych Trait Measure
- OTHER Vaccine-Specific Psych Trait Measures
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,786 participants |
| Start Date | 2022-12-30 |
| Est. Completion | 2025-02-27 |
| Phase | NA |
What the finished NCT07172074 record still lists
NCT07172074 is an interventional study that assigns participants to a tested intervention. Its 1,786 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (27% higher).
The record links to 0 conditions, and to 2 interventions - of which General Psych Trait Measure is the first listed.
NCT07172074 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07172074 about?
NCT07172074 is a clinical study titled "Comparing Relative Strengths of Statistical Associations Between Psychological Traits and Vaccination-Related Outcomes I". The goal of this study was to identify psychological motives that had the strongest statistical associations with vaccine outcomes in order to identify novel intervention targets to be used in vaccine promotion efforts. A national sample of US adults completed an online survey containing a variety o...
What is the current status of trial NCT07172074?
This trial is currently completed. It is a NA study. The enrollment target is 1,786 participants. The study started on 2022-12-30. Estimated completion is 2025-02-27.
What interventions are being tested in trial NCT07172074?
The interventions under investigation include: General Psych Trait Measure (DIAGNOSTIC_TEST), Vaccine-Specific Psych Trait Measures (OTHER).
Who is sponsoring clinical trial NCT07172074?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07172074's enrollment target sits among peer trials
1,786 59th of 2000 higher than 1,942 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05770570 · 1,785 participants · Phase 2
Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)
- NCT03067181 · 1,780 participants · Phase 3
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
- NCT06526650 · 1,780 participants · NA
'Ai Pono Cooking Demonstrations
- NCT03630055 · 1,800 participants · Phase 3
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI